Vyvanse / Lisdexamfetamine → 🇳🇿 New Zealand

Full details

Vyvanse / Lisdexamfetamine may require documentation or declaration. Quantity guidance for New Zealand: Up to 3-month personal supply under Misuse of Drugs Act 1975 personal exemption. Documentation: Original prescription from licensed physician; Medication in original pharmacy-labelled packaging; Doctor's letter (strongly recommended). Enforcement in New Zealand carries fines from NZD 400 to NZD 5,000 under Biosecurity Act 1993 s.157, s.155; Customs and Excise Act 2018 (typical personal cases are handled as civil infringements).

Leaving New Zealand with vyvanse / lisdexamfetamine

Lisdexamfetamine is a Schedule II-equivalent controlled stimulant under the Misuse of Drugs Act 1975; Customs and Excise Act 2018 framework. Personal-use quantities (typically ≤30-90 days' supply) accompanied by the prescription and doctor's letter are generally permitted for export from New Zealand; above these limits a Medsafe personal export authorisation is required in advance. Destination-side treatment is the sharper risk — several countries (Japan requires advance permission; some jurisdictions ban amphetamine-class medicines outright) restrict arrival with stimulant ADHD medication, so verify the arrival rule for the same route.

OFFICIAL SOURCES · VERIFIED 2026-07-25